Lequn Zhao

Title: Lequn Zhao: Innovator in Biopharmaceuticals

Introduction

Lequn Zhao is a prominent inventor based in San Carlos, CA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies. With a total of 3 patents, Zhao's work has the potential to impact various medical applications.

Latest Patents

Zhao's latest patents include "IL13 AND IL31 BISPECIFIC POLYPEPTIDES AND USES THEREOF" and "Humanized anti-CD45 antibodies." The first patent focuses on bispecific polypeptides that target interleukins, which are crucial in immune responses. The second patent provides humanized anti-human CD45 antibodies and pharmaceutical compositions that include these antibodies, showcasing his expertise in antibody engineering.

Career Highlights

Throughout his career, Lequn Zhao has worked with notable companies such as Actinium Pharmaceuticals and Attovia Therapeutics. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the biopharmaceutical sector.

Collaborations

Zhao has collaborated with esteemed colleagues, including David Bellovin and Lam Nguyen. These partnerships have fostered an environment of innovation and creativity, leading to advancements in therapeutic solutions.

Conclusion

Lequn Zhao's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for new therapeutic approaches that can benefit patients worldwide.